Fred Hutchinson Cancer Res. Ctr.

Combination HRT doubles breast density, quadruples risk of abnormal mammograms

Published in Nursing Home and Elder Business Week, November 14th, 2004

Postmenopausal women who take combination estrogen-plus-progestin hormone replacement therapy (HRT) for 1 year experience a two-fold increase in breast density - a known risk factor for breast cancer - and a quadrupled risk of having an abnormal mammogram, according to new findings from a sub-study of the Women's Health Initiative (WHI).

Lead investigator Anne McTiernan, MD, PhD, of Fred Hutchinson Cancer Research Center in Seattle, Washington, presented these findings on October 18, 2004, at the third annual International Conference on Frontiers in Cancer Prevention Research hosted by the American Association for Cancer Research.

"I was surprised by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Nursing Home and Elder Business Week

Source: Nursing Home and Elder Business Week (2004-11-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry